Nello Mainolfi, CEO: Kymera Therapeutics KYMR Sell · Filed 04/29

Trade details

Type: Insider sale
Amount: $1,372,983.7
Shares · price: 17,005 sh · $80.74 a share
Held after: 679,190 sh
Stock: Kymera Therapeutics KYMR
Person: Nello MainolfiCEO
Trade date: 26/04/29
Filed: 26/04/29
Days to filing: 0 days

Sold 2.4% of holdings

Share of holding sold: 2.4%

Kymera Therapeutics trades, last 26 weeks

What else happened in Kymera Therapeutics around then

Filed or reported within 30 days of the trade day · 03/30~05/29

Nello Mainolfi's recent trades

Nello MainolfiCEO
Planned sale10b5-1 planKymera Therapeutics
Planned sale10b5-1 plan
Kymera Therapeutics
KYMR
$6M
50,000 sh
$6M
Filed 07/07
Traded 07/07
Nello MainolfiCEO
Planned sale10b5-1 planKymera Therapeutics
Planned sale10b5-1 plan
Kymera Therapeutics
KYMR
$9.1M
80,000 sh
$9.1M
Filed 07/02
Traded 07/01
Nello MainolfiCEO
Sell10b5-1 planKymera Therapeutics
Sell10b5-1 plan
Kymera Therapeutics
KYMR
$985.2K
12,059 sh
$985.2K
Filed 04/29
Traded 04/29
Nello MainolfiCEO
Sell10b5-1 planKymera Therapeutics
Sell10b5-1 plan
Kymera Therapeutics
KYMR
$77.2K
936 sh
$77.2K
Filed 04/29
Traded 04/29
Nello MainolfiCEO
Planned sale10b5-1 planKymera Therapeutics
Planned sale10b5-1 plan
Kymera Therapeutics
KYMR
$2.5M
30,000 sh
$2.5M
Filed 04/29
Traded 04/29

Nello Mainolfi, CEO — sold $1.4M of Kymera Therapeutics KYMR · 2.4% of holdings · 10b5-1 plan | Whalegun